| Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response M Pagadala, TJ Sears, VH Wu, E Pérez-Guijarro, H Kim, A Castro, ... Nature communications 14 (1), 2744, 2023 | 10 | 2023 |
| PRState: Incorporating genetic ancestry in prostate cancer risk scores for men of African ancestry MS Pagadala, JA Linscott, JV Talwar, TM Seibert, B Rose, J Lynch, ... BMC cancer 22 (1), 1289, 2022 | 2 | 2022 |
| Germline variants that influence the tumor immune microenvironment also drive response to immunotherapy M Pagadala, VH Wu, E Pérez-Guijarro, H Kim, A Castro, J Talwar, ... BioRxiv, 2021 | 2 | 2021 |
| PRState: Incorporating Genetic Ancestry in Prostate Cancer Risk scores for African American Men MS Pagadala, JA Linscott, J Talwar, T Seibert, B Rose, J Lynch, ... medRxiv, 2022.03. 12.22271020, 2022 | 1 | 2022 |
| Predictive analyses of regulatory sequences with EUGENe A Klie, D Laub, JV Talwar, H Stites, T Jores, JJ Solvason, EK Farley, ... Nature Computational Science 3 (11), 946-956, 2023 | | 2023 |
| Autoimmune HLA Alleles and Neoepitope Presentation Predict Post-Allogenic Transplant Relapse A Castro, AM Goodman, Z Rane, JV Talwar, GM Frampton, GP Morris, ... Journal of Immunotherapy and Precision Oncology 6 (3), 127-132, 2023 | | 2023 |
| Autoimmune alleles at the major histocompatibility locus modify melanoma susceptibility JV Talwar, D Laub, MS Pagadala, A Castro, MK Lewis, GE Luebeck, ... The American Journal of Human Genetics 110 (7), 1138-1161, 2023 | | 2023 |
| Epigenetic germline variants predict cancer prognosis and risk and distribute uniquely in topologically associating domains S Goudarzi, M Pagadala, A Klie, J Talwar, H Carter bioRxiv, 2023.07. 04.547722, 2023 | | 2023 |
| Interpretation of machine learning methods for the prediction of breast and prostate cancer risk A Klie, J Talwar, M Pagadala, H Carter Cancer Research 82 (12_Supplement), 1942-1942, 2022 | | 2022 |
| Germline modifiers of the tumor immune microenvironment reveal drivers of immunotherapy response M Pagadala, V Wu, E Pérez-Guijarro, H Kim, A Castro, J Talwar, ... Cancer Research 82 (12_Supplement), 3825-3825, 2022 | | 2022 |
| Assessing cancer drug response prediction from gene expression J Talwar, H Carter Cancer Research 80 (16_Supplement), 2099-2099, 2020 | | 2020 |
